SLDB
Solid Biosciences is a biotech company focused on advancing precision genetic medicines with a portfolio of gene therapy candidates for rare neuromuscular and cardiac diseases. The company emphasizes Duchenne muscular dystrophy and other genetic conditions, while also pursuing genetic regulators and enabling technologies to improve gene delivery. Headquartered in Charlestown, Massachusetts, Solid collaborates with researchers to develop therapies aimed at patients affected by life‑threatening neuromuscular and cardiac disorders.
No recent deals for this company.